Liposomal conjugates for drug delivery to the central nervous system

Treatments of central nervous system (CNS) diseases often fail due to the blood-brain barrier. Circumvention of this obstacle is crucial for any systemic treatment of such diseases to be effective. One approach to transfer drugs into the brain is the use of colloidal carrier systems—amongst others,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Helm, Frieder (VerfasserIn) , Fricker, Gert (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 April 2015
In: Pharmaceutics
Year: 2015, Jahrgang: 7, Heft: 2, Pages: 27-42
ISSN:1999-4923
DOI:10.3390/pharmaceutics7020027
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/pharmaceutics7020027
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1999-4923/7/2/27
Volltext
Verfasserangaben:Frieder Helm, Gert Fricker

MARC

LEADER 00000caa a2200000 c 4500
001 1727146271
003 DE-627
005 20230427022507.0
007 cr uuu---uuuuu
008 200817s2015 xx |||||o 00| ||eng c
024 7 |a 10.3390/pharmaceutics7020027  |2 doi 
035 |a (DE-627)1727146271 
035 |a (DE-599)KXP1727146271 
035 |a (OCoLC)1341355080 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Helm, Frieder  |e VerfasserIn  |0 (DE-588)1031276165  |0 (DE-627)736110119  |0 (DE-576)378714600  |4 aut 
245 1 0 |a Liposomal conjugates for drug delivery to the central nervous system  |c Frieder Helm, Gert Fricker 
264 1 |c 1 April 2015 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.08.2020 
520 |a Treatments of central nervous system (CNS) diseases often fail due to the blood-brain barrier. Circumvention of this obstacle is crucial for any systemic treatment of such diseases to be effective. One approach to transfer drugs into the brain is the use of colloidal carrier systems—amongst others, liposomes. A prerequisite for successful drug delivery by colloidal carriers to the brain is the modification of their surface, making them invisible to the reticuloendothelial system (RES) and to target them to specific surface epitopes at the blood-brain barrier. This study characterizes liposomes conjugated with cationized bovine serum albumin (cBSA) as transport vectors in vitro in porcine brain capillary endothelial cells (PBCEC) and in vivo in rats using fluorescently labelled liposomes. Experiments with PBCEC showed that sterically stabilized (PEGylated) liposomes without protein as well as liposomes conjugated to native bovine serum albumin (BSA) were not taken up. In contrast, cBSA-liposomes were taken up and appeared to be concentrated in intracellular vesicles. Uptake occurred in a concentration and time dependent manner. Free BSA and free cBSA inhibited uptake. After intravenous application of cBSA-liposomes, confocal fluorescence microscopy of brain cryosections from male Wistar rats showed fluorescence associated with liposomes in brain capillary surrounding tissue after 3, 6 and 24 h, for liposomes with a diameter between 120 and 150 nm, suggesting successful brain delivery of cationized-albumin coupled liposomes. 
650 4 |a blood-brain barrier 
650 4 |a brain capillary endothelial 
650 4 |a cationized bovine serum albumin 
650 4 |a liposomal conjugates 
650 4 |a liposomes 
700 1 |a Fricker, Gert  |d 1956-  |e VerfasserIn  |0 (DE-588)1042227675  |0 (DE-627)768469465  |0 (DE-576)393783464  |4 aut 
773 0 8 |i Enthalten in  |t Pharmaceutics  |d Basel : MDPI, 2009  |g 7(2015), 2, Seite 27-42  |h Online-Ressource  |w (DE-627)614096529  |w (DE-600)2527217-2  |w (DE-576)313958653  |x 1999-4923  |7 nnas  |a Liposomal conjugates for drug delivery to the central nervous system 
773 1 8 |g volume:7  |g year:2015  |g number:2  |g pages:27-42  |g extent:16  |a Liposomal conjugates for drug delivery to the central nervous system 
856 4 0 |u https://doi.org/10.3390/pharmaceutics7020027  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1999-4923/7/2/27  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200817 
993 |a Article 
994 |a 2015 
998 |g 1042227675  |a Fricker, Gert  |m 1042227675:Fricker, Gert  |d 160000  |d 160100  |e 160000PF1042227675  |e 160100PF1042227675  |k 0/160000/  |k 1/160000/160100/  |p 2  |y j 
998 |g 1031276165  |a Helm, Frieder  |m 1031276165:Helm, Frieder  |d 160000  |d 160100  |e 160000PH1031276165  |e 160100PH1031276165  |k 0/160000/  |k 1/160000/160100/  |p 1  |x j 
999 |a KXP-PPN1727146271  |e 3740484462 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Frieder","display":"Helm, Frieder","family":"Helm"},{"display":"Fricker, Gert","given":"Gert","role":"aut","family":"Fricker"}],"name":{"displayForm":["Frieder Helm, Gert Fricker"]},"physDesc":[{"extent":"16 S."}],"id":{"eki":["1727146271"],"doi":["10.3390/pharmaceutics7020027"]},"relHost":[{"pubHistory":["1.2009 -"],"part":{"extent":"16","pages":"27-42","issue":"2","year":"2015","text":"7(2015), 2, Seite 27-42","volume":"7"},"language":["eng"],"title":[{"title":"Pharmaceutics","title_sort":"Pharmaceutics"}],"note":["Gesehen am 28.05.14"],"disp":"Liposomal conjugates for drug delivery to the central nervous systemPharmaceutics","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2527217-2"],"issn":["1999-4923"],"eki":["614096529"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"614096529","origin":[{"publisherPlace":"Basel","dateIssuedDisp":"2009-","publisher":"MDPI","dateIssuedKey":"2009"}],"name":{"displayForm":["Molecular Diversity Preservation International"]}}],"note":["Gesehen am 17.08.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1727146271","origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"1 April 2015"}],"title":[{"title_sort":"Liposomal conjugates for drug delivery to the central nervous system","title":"Liposomal conjugates for drug delivery to the central nervous system"}],"language":["eng"]} 
SRT |a HELMFRIEDELIPOSOMALC1201